Literature DB >> 24739981

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.

E Ruppé1, L Armand-Lefèvre, C Estellat, A El-Mniai, Y Boussadia, P H Consigny, P M Girard, D Vittecoq, O Bouchaud, G Pialoux, M Esposito-Farèse, B Coignard, J C Lucet, A Andremont, S Matheron.   

Abstract

Healthy travellers to countries where carbapenemases-producing Enterobacteriaceae (CPE) are endemic might be at risk for their acquisition, even without contact with the local healthcare system. Here, we report the acquisition of CPE (two OXA-181, one New Delhi metallo-beta-lactamase 1 (NDM-1)) in three healthy travellers returning from India. The duration of CPE intestinal carriage was less than one month. The results indicate that healthy travellers recently returning from India might be considered as at risk for CPE carriage.

Mesh:

Substances:

Year:  2014        PMID: 24739981     DOI: 10.2807/1560-7917.es2014.19.14.20768

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  24 in total

Review 1.  Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.

Authors:  Dirk Vogelaers; Stijn Blot; Andries Van den Berge; Philippe Montravers
Journal:  Drugs       Date:  2021-05-26       Impact factor: 9.546

Review 2.  Antibiotic use and emerging resistance: how can resource-limited countries turn the tide?

Authors:  Lisa M Bebell; Anthony N Muiru
Journal:  Glob Heart       Date:  2014-10-31

3.  First Report of OXA-181-Producing Escherichia coli in China and Characterization of the Isolate Using Whole-Genome Sequencing.

Authors:  Yanbin Liu; Yu Feng; Wenjing Wu; Yi Xie; Xiaohui Wang; Xiaoxia Zhang; Xinchuan Chen; Zhiyong Zong
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

Review 4.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

5.  The Human Gut Microbiome as a Transporter of Antibiotic Resistance Genes between Continents.

Authors:  Johan Bengtsson-Palme; Martin Angelin; Mikael Huss; Sanela Kjellqvist; Erik Kristiansson; Helena Palmgren; D G Joakim Larsson; Anders Johansson
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

6.  Characteristics of Carbapenemase-Producing Enterobacteriaceae in Wastewater Revealed by Genomic Analysis.

Authors:  Ryota Gomi; Tomonari Matsuda; Masaki Yamamoto; Pei-Hsin Chou; Michio Tanaka; Satoshi Ichiyama; Minoru Yoneda; Yasufumi Matsumura
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 7.  OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Authors:  Assia Mairi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Aziz Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-08       Impact factor: 3.267

Review 8.  Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China.

Authors:  Vincent C C Cheng; Sally C Y Wong; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2015-02-11       Impact factor: 7.163

9.  High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors.

Authors:  Esther Kuenzli; Veronika K Jaeger; Reno Frei; Andreas Neumayr; Susan DeCrom; Sabine Haller; Johannes Blum; Andreas F Widmer; Hansjakob Furrer; Manuel Battegay; Andrea Endimiani; Christoph Hatz
Journal:  BMC Infect Dis       Date:  2014-10-01       Impact factor: 3.090

10.  Mechanisms of antimicrobial resistance in Gram-negative bacilli.

Authors:  Étienne Ruppé; Paul-Louis Woerther; François Barbier
Journal:  Ann Intensive Care       Date:  2015-08-12       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.